Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke-Fei Dou

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Nuclear Medicine Communications|March 15, 2006
Prognostic value of normal exercise 99mTc-sestamibi myocardial tomography in patients with angiographic coronary artery diseaseMin-Fu Yang, Ke-Fei Dou, Xiu-Jie Liu, et al.
Cardiovascular Drugs and Therapy|July 1, 2020
Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization GuidelineHao-Yu Wang, Ke-Fei Dou, Yang Wang, et al.
BMC Cardiovascular Disorders|July 3, 2020
Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCIHao-Yu Wang, Ke-Fei Dou, Dong Yin, et al.
BMC Cardiovascular Disorders|May 12, 2017
Dual-time-point myocardial <sup>18</sup>F-FDG imaging in the detection of coronary artery diseaseKe-Fei Dou, Xiao-Jin Gao, Bo-Qia Xie, et al.
Chinese Medical Journal|July 12, 2011
Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature reviewXiao-Jin Gao, Lian-Ming Kang, Jian Zhang, et al.
Chinese Medical Journal|April 19, 2013
Protein kinase A-mediated cardioprotection of Tongxinluo relates to the inhibition of myocardial inflammation, apoptosis, and edema in reperfused swine heartsXiang-dong Li, Yue-jin Yang, Yu-tong Cheng, et al.
Chinese Medical Journal|December 24, 2008
Acute and reversible cardiomyopathy provoked by stress in a Chinese womanLian-ming Kang, Jian Zhang, Ke-fei Dou, et al.
The American Journal of Cardiology|December 7, 2020
Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes MellitusHao-Yu Wang, Zhong-Xing Cai, Dong Yin, et al.
Journal of Atherosclerosis and Thrombosis|March 22, 2021
Prognostic and Practical Validation of ESC/EACTS High Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary PCI PatientsHao-Yu Wang, Dong Yin, Yan-Yan Zhao, et al.
Journal of Interventional Cardiology|May 15, 2020
Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort StudyHao-Yu Wang, Yang Wang, Dong Yin, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Nuclear Medicine Communications|March 15, 2006
Prognostic value of normal exercise 99mTc-sestamibi myocardial tomography in patients with angiographic coronary artery diseaseMin-Fu Yang, Ke-Fei Dou, Xiu-Jie Liu, et al.
Cardiovascular Drugs and Therapy|July 1, 2020
Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization GuidelineHao-Yu Wang, Ke-Fei Dou, Yang Wang, et al.
BMC Cardiovascular Disorders|July 3, 2020
Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCIHao-Yu Wang, Ke-Fei Dou, Dong Yin, et al.
BMC Cardiovascular Disorders|May 12, 2017
Dual-time-point myocardial <sup>18</sup>F-FDG imaging in the detection of coronary artery diseaseKe-Fei Dou, Xiao-Jin Gao, Bo-Qia Xie, et al.
Chinese Medical Journal|July 12, 2011
Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature reviewXiao-Jin Gao, Lian-Ming Kang, Jian Zhang, et al.
Chinese Medical Journal|April 19, 2013
Protein kinase A-mediated cardioprotection of Tongxinluo relates to the inhibition of myocardial inflammation, apoptosis, and edema in reperfused swine heartsXiang-dong Li, Yue-jin Yang, Yu-tong Cheng, et al.
Chinese Medical Journal|December 24, 2008
Acute and reversible cardiomyopathy provoked by stress in a Chinese womanLian-ming Kang, Jian Zhang, Ke-fei Dou, et al.
The American Journal of Cardiology|December 7, 2020
Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes MellitusHao-Yu Wang, Zhong-Xing Cai, Dong Yin, et al.
Journal of Atherosclerosis and Thrombosis|March 22, 2021
Prognostic and Practical Validation of ESC/EACTS High Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary PCI PatientsHao-Yu Wang, Dong Yin, Yan-Yan Zhao, et al.
Journal of Interventional Cardiology|May 15, 2020
Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort StudyHao-Yu Wang, Yang Wang, Dong Yin, et al.
Pageof 12